Related Experiment Video
Updated: May 1, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Pharmacological strategies to prevent contrast-induced acute kidney injury
Pattharawin Pattharanitima1, Adis Tasanarong1
1Nephrology Unit, Department of Medicine, Faculty of Medicine, Thammasat University (Rangsit Campus), Klong Luang, Pathumtani 12121, Thailand.
Insights
Contrast-induced acute kidney injury (CI-AKI) is a significant risk for patients undergoing contrast media procedures. This review examines pharmacological strategies to prevent CI-AKI in high-risk individuals.
Area of Science:
- Nephrology
- Radiology
- Pharmacology
Background:
- Contrast-induced acute kidney injury (CI-AKI) is a common complication following intravenous contrast media administration.
- CI-AKI incidence is low in healthy individuals but significantly elevated in patients with chronic kidney disease, diabetes, advanced age, and other risk factors.
- CI-AKI contributes to prolonged hospital stays, increased morbidity, and mortality, particularly in high-risk populations.
Purpose of the Study:
- To critically evaluate the current evidence for pharmacological strategies aimed at preventing CI-AKI.
- To identify effective treatments for high-risk patients susceptible to contrast-induced nephropathy.
Main Methods:
- Systematic review of experimental studies and clinical trials.
- Critical evaluation of existing evidence on CI-AKI prevention.
Main Results:
- Intravascular volume expansion with saline or sodium bicarbonate is currently recommended for CI-AKI prevention.
- Despite current strategies, a notable proportion of at-risk patients still develop CI-AKI.
- Pharmacological interventions beyond volume expansion require further investigation.
Conclusions:
- While volume expansion is a cornerstone of CI-AKI prevention, it is not universally effective.
- Further research into pharmacological strategies is crucial for improving CI-AKI prevention in high-risk patients.
- Developing novel preventative treatments is essential to reduce the burden of CI-AKI.
Abstract:
Contrast-induced acute kidney injury (CI-AKI) is the most common iatrogenic cause of acute kidney injury after intravenous contrast media administration. In general, the incidence of CI-AKI is low in patients with normal renal function. However, the rate is remarkably elevated in patients with preexisting chronic kidney disease, diabetes mellitus, old age, high volume of contrast agent, congestive heart failure, hypotension, anemia, use of nephrotoxic drug, and volume depletion. Consequently, CI-AKI particularly in high risk patients contributes to extended hospitalizations and increases long-term morbidity and mortality. The pathogenesis of CI-AKI involves at least three mechanisms; contrast agents induce renal vasoconstriction, increase of oxygen free radicals through oxidative stress, and direct tubular toxicity. Several strategies to prevent CI-AKI have been evaluated in experimental studies and clinical trials. At present, intravascular volume expansion with either isotonic saline or sodium bicarbonate solutions has provided more consistent positive results and was recommended in the prevention of CI-AKI. However, the proportion of patients with risk still develops CI-AKI. This review critically evaluated the current evidence for pharmacological strategies to prevent CI-AKI in patients with a risk of developing CI-AKI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury I: Introduction
Imaging Studies VII: Vascular Imaging

